SAN DIEGO — Arcturus Therapeutics Holdings Inc., a leading clinical-stage messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare diseases and vaccines, today announced new supportive preclinical data, providing evidence for an adaptive cellular (CD8+ … Continue reading Arcturus: Preclinical Data for COVID-19 Vaccine →